Irving, Melita http://orcid.org/0000-0002-6849-7194
Ortiz-Miranda, Yaquelin
Coukos, George http://orcid.org/0000-0001-8813-7367
Article History
First Online: 6 December 2022
Competing interests
: G.C. has received grants or research support from, or is coinvestigator in clinical trials by, Bristol-Myers Squibb, Celgene, Boehringer Ingelheim, Roche, Tigen Pharma, Iovance and Kite. The Lausanne University Hospital (CHUV) has received honoraria for advisory services G.C. has provided to AstraZeneca AG, Bristol-Myers Squibb SA, F. Hoffmann-La Roche AG, MSD Merck AG and Geneos Therapeutics. G.C. has patents in the domain of antibodies and vaccines targeting the tumour vasculature as well as technologies related to T cell expansion and engineering for T cell therapy. G.C. has received royalties from the University of Pennsylvania. The three co-authors are included in an intellectual property filing regarding an IL-2 variant.